1. Despite healthy EPS growth expected in the upcoming results, it's challenging to make a short-to-medium term Buy case for Philip Morris due to its strong price gains this year. 2. The stock's market multiples are currently high, and with market prospects looking decent for Q4 2024, a shift towards defensive stocks seems unlikely. 3. The author notes that the stock's forward non-GAAP P/E ratio was high even before writing, indicating the risk of short-term investment.